Table 3: Summary of the statistical analysis for the study groups (M2).

Secondary outcomesPreintervention (M0) valuePostintervention (M2) value
Group L ()
Mean ± standard deviation
Group P ()
Mean ± standard deviation
Group L ()
Mean ± standard deviation
Group P ()
Mean ± standard deviation

LT4 dose (μg/day)93.48 ± 44.0990.00 ± 40.880.79194.50 ± 44.45141.72 ± 52.620.003
LT4 dose (μg/kg/day)1.32 ± 0.601.25 ± 0.550.6931.31 ± 0.721.86 ± 0.530.010
Total T3 (ng/mL)124.04 ± 21.21120.35 ± 20.020.563107.25 ± 17.77104.17 ± 18.660.589
Total T4 (μg/dL)9.92 ± 1.609.73 ± 1.950.73810.27 ± 1.7210.15 ± 2.330.848
Free T4 (ng/dL)1.03 ± 0.151.03 ± 0.200.9971.28 ± 0.211.28 ± 0.330.955
TSH (μIU/mL)2.65 ± 1.362.88 ± 1.410.5791.82 ± 1.132.25 ± 1.910.397
Thyroid volume (cm3)14.24 ± 9.7816.32 ± 23.650.70211.03 ± 5.9714.80 ± 19.830.375
Mean of left and right ITA-PSV (cm/s)28.34 ± 10.9527.31 ± 8.740.73820.23 ± 6.6817.60 ± 7.070.220
Mean of left and right ITA-RI mean0.56 ± 0.070.57 ± 0.070.4230.60 ± 0.080.64 ± 0.080.351

-test for independent samples; .